Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, liuos, esitäytetty ruisku) ha
HUS-Yhtymä tender for Healthcare & Medical, worth €10.5M, published in July 2025.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, liuos, esitäytetty ruisku) hankinta RSV-kaudelle 2025-2026
Other tenders · HUS-Yhtymä
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-831207-2025€60.0K14 Jul 2025 Professional Services
- ocds-ted-747546-2025-4Not disclosed17 Jan 2025 Healthcare
- ocds-ted-747546-2025-3Not disclosed17 Jan 2025 Healthcare
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime